Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical -6-MTH group results

Nov 13 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             6.56                8.05             15.73     
                 (-18.5 pct)         (+3.0 pct)       (-11.8 pct)  
  Operating       loss 2.39         loss 869 mln       loss 1.98   
  Recurring       loss 2.64         loss 522 mln       loss 2.67   
  Net               1.03            loss 759 mln        108 mln    
  EPS             25.83 yen        loss 19.08 yen      2.71 yen    
  Ann Div                                NIL                       
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL                       
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Shin Nippon Biomedical Laboratories

See all news